Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Newborn, Diseases | 3 | 2023 | 179 | 1.880 |
Why?
|
| Zika Virus Infection | 5 | 2019 | 164 | 1.730 |
Why?
|
| Infant, Extremely Premature | 4 | 2024 | 80 | 1.470 |
Why?
|
| Zika Virus | 4 | 2019 | 144 | 1.290 |
Why?
|
| Milk, Human | 4 | 2024 | 306 | 1.280 |
Why?
|
| Infant Health | 2 | 2019 | 14 | 1.270 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 420 | 1.210 |
Why?
|
| Global Health | 3 | 2024 | 672 | 1.160 |
Why?
|
| Infant, Newborn | 18 | 2024 | 8603 | 1.000 |
Why?
|
| Microbiota | 3 | 2019 | 545 | 0.910 |
Why?
|
| Weight Loss | 3 | 2024 | 626 | 0.860 |
Why?
|
| Patient Care Bundles | 1 | 2023 | 31 | 0.860 |
Why?
|
| Bioethics | 1 | 2024 | 71 | 0.840 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2024 | 193 | 0.830 |
Why?
|
| Body Fluids | 1 | 2023 | 121 | 0.830 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2020 | 229 | 0.790 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 34 | 0.720 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 145 | 0.700 |
Why?
|
| Health Resources | 1 | 2021 | 170 | 0.660 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 239 | 0.640 |
Why?
|
| Mentoring | 1 | 2021 | 105 | 0.640 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 695 | 0.640 |
Why?
|
| Microcephaly | 4 | 2019 | 328 | 0.620 |
Why?
|
| Mentors | 1 | 2021 | 209 | 0.620 |
Why?
|
| Metagenomics | 1 | 2019 | 122 | 0.610 |
Why?
|
| Mothers | 1 | 2021 | 406 | 0.610 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 541 | 0.610 |
Why?
|
| Maternal Health | 1 | 2018 | 14 | 0.610 |
Why?
|
| Metagenome | 1 | 2019 | 192 | 0.600 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 562 | 0.550 |
Why?
|
| Growth Disorders | 1 | 2018 | 223 | 0.540 |
Why?
|
| Patient Discharge | 1 | 2021 | 699 | 0.540 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 971 | 0.530 |
Why?
|
| Pregnancy | 10 | 2023 | 7916 | 0.520 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 115 | 0.510 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2014 | 74 | 0.470 |
Why?
|
| Fetal Diseases | 1 | 2018 | 457 | 0.450 |
Why?
|
| Infant, Premature | 3 | 2024 | 832 | 0.450 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 277 | 0.440 |
Why?
|
| Premature Birth | 1 | 2018 | 375 | 0.440 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 182 | 0.400 |
Why?
|
| Child Development | 2 | 2024 | 266 | 0.390 |
Why?
|
| Internship and Residency | 1 | 2021 | 1439 | 0.330 |
Why?
|
| Prenatal Care | 2 | 2023 | 295 | 0.300 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2021 | 313 | 0.300 |
Why?
|
| Humans | 23 | 2024 | 270637 | 0.260 |
Why?
|
| Female | 15 | 2024 | 148834 | 0.240 |
Why?
|
| Environmental Health | 1 | 2024 | 14 | 0.230 |
Why?
|
| Social Justice | 1 | 2024 | 56 | 0.220 |
Why?
|
| Brain | 5 | 2024 | 4198 | 0.210 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2024 | 461 | 0.200 |
Why?
|
| Birth Weight | 1 | 2024 | 323 | 0.200 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 172 | 0.200 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 187 | 0.200 |
Why?
|
| Infant | 5 | 2024 | 13994 | 0.200 |
Why?
|
| Maternal Mortality | 1 | 2020 | 62 | 0.180 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2021 | 170 | 0.170 |
Why?
|
| Breast Feeding | 1 | 2021 | 248 | 0.170 |
Why?
|
| Drug Utilization | 1 | 2020 | 185 | 0.160 |
Why?
|
| Malawi | 1 | 2020 | 392 | 0.160 |
Why?
|
| Gestational Age | 2 | 2023 | 1160 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2024 | 773 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2018 | 63 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 639 | 0.140 |
Why?
|
| Americas | 1 | 2016 | 55 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 699 | 0.130 |
Why?
|
| Brazil | 1 | 2016 | 163 | 0.130 |
Why?
|
| Fetus | 1 | 2019 | 670 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 350 | 0.130 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 43 | 0.120 |
Why?
|
| Probiotics | 1 | 2018 | 241 | 0.120 |
Why?
|
| Exanthema | 1 | 2017 | 213 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2014 | 35 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 562 | 0.120 |
Why?
|
| Fever of Unknown Origin | 1 | 2014 | 60 | 0.120 |
Why?
|
| Fungemia | 1 | 2014 | 119 | 0.120 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 144 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2014 | 179 | 0.110 |
Why?
|
| Granulocytes | 1 | 2014 | 244 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2014 | 278 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2014 | 235 | 0.110 |
Why?
|
| Skin | 1 | 2017 | 1280 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1607 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2014 | 1169 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2024 | 17071 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1217 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 1091 | 0.080 |
Why?
|
| Male | 6 | 2024 | 128446 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 4837 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 2356 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 3392 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 1436 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2022 | 13406 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 7317 | 0.060 |
Why?
|
| Disease Progression | 1 | 2014 | 6880 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 9053 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 238 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 509 | 0.040 |
Why?
|
| United States | 1 | 2016 | 15813 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 39954 | 0.040 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 51 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 786 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 39 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 39 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 61 | 0.040 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 61 | 0.040 |
Why?
|
| Blueberry Plants | 1 | 2017 | 5 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 125 | 0.040 |
Why?
|
| Adult | 3 | 2019 | 82023 | 0.040 |
Why?
|
| Mice | 1 | 2018 | 35414 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 271 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1408 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2018 | 259 | 0.030 |
Why?
|
| Calcinosis | 1 | 2018 | 427 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 799 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 923 | 0.030 |
Why?
|
| Animals | 1 | 2018 | 61340 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 2045 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 1174 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 22238 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 15274 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7646 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6502 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9450 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7916 | 0.010 |
Why?
|
| Child | 1 | 2023 | 30558 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 32687 | 0.010 |
Why?
|